Concepedia

James D. Hallman

JD

Statistics

Publications

4

Citations

492

H-Index

4

Active since

1995

Affiliations

St. Jude Children's Research Hospital(Current)

Duke Medical Center

James D. Hallman is an author at St. Jude Children's Research Hospital specializing in medicine, pharmacology, and oncology.

Publications per year

1995–1996

4

Publications

4

Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors

Peter J. Houghton, Pamela J. Cheshire, James D. Hallman et al. · Cancer Chemotherapy and Pharmacology · 1995 · 407 citations

, , +12

Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.

Janet A. Houghton, Pamela J. Cheshire, James D. Hallman et al. · PubMed · 1996 · 45 citations

, , +10

Therapeutic efficacy of the cyclopropylpyrroloindole, carzelesin, against xenografts derived from adult and childhood solid tumors

Peter J. Houghton, Pamela J. Cheshire, James D. Hallman et al. · Cancer Chemotherapy and Pharmacology · 1995 · 20 citations

, , +9

Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors

Peter J. Houghton, Pamela J. Cheshire, James D. Hallman et al. · Cancer Chemotherapy and Pharmacology · 1995 · 20 citations

, , +12

1–4 of 4